Cardlytics Inc (CDLX) - Total Liabilities

Latest as of March 2026: $267.91 Million USD

Based on the latest financial reports, Cardlytics Inc (CDLX) has total liabilities worth $267.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Cardlytics Inc cash conversion from operations to assess how effectively this company generates cash.

Cardlytics Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how Cardlytics Inc's total liabilities have evolved over time, based on quarterly financial data. Check Cardlytics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Cardlytics Inc Competitors by Total Liabilities

The table below lists competitors of Cardlytics Inc ranked by their total liabilities.

Company Country Total Liabilities
Marti Gayrimenkul Yatirim Ortakligi AS
IS:MRGYO
Turkey TL3.99 Billion
dMY Squared Technology Group Inc
NYSE MKT:DMYY
USA $27.18 Million
Kentucky First Federal Bancorp
NASDAQ:KFFB
USA $326.18 Million
FNC Entertainment Co Ltd
KQ:173940
Korea ₩90.65 Billion
Xilio Development Inc
NASDAQ:XLO
USA $141.79 Million
Neofect Co.Ltd
KQ:290660
Korea ₩24.61 Billion
Panjawattana Plastic Public Company Limited
BK:PJW
Thailand ฿2.25 Billion
Inchcape PLC
LSE:INCH
UK GBX4.61 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Cardlytics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Cardlytics Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -66.93 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.02 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cardlytics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cardlytics Inc (2015–2025)

The table below shows the annual total liabilities of Cardlytics Inc from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $292.15 Million -9.47%
2024-12-31 $322.72 Million -26.55%
2023-12-31 $439.35 Million -8.40%
2022-12-31 $479.63 Million -16.31%
2021-12-31 $573.10 Million +115.98%
2020-12-31 $265.35 Million +227.40%
2019-12-31 $81.05 Million -20.38%
2018-12-31 $101.79 Million -67.11%
2017-12-31 $309.44 Million +1.89%
2016-12-31 $303.69 Million +24.24%
2015-12-31 $244.45 Million --

About Cardlytics Inc

NASDAQ:CDLX USA Advertising Agencies
Market Cap
$39.92 Million
Market Cap Rank
#23120 Global
#4919 in USA
Share Price
$0.69
Change (1 day)
-4.89%
52-Week Range
$0.60 - $3.12
All Time High
$157.18
About

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-o… Read more